序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
1 PHOTOCLEAVABLE LINKER US14083938 2013-11-19 US20140154775A1 2014-06-05 John C. Williams; David Horne; Jun Xie; Shubbir Ahmed
There are provided, inter alia, photolabile compounds and methods useful for the formation of dimers of biological molecules and subsequent dissociation of the dimers.
2 INDUCED ACTIVATION IN DENDRITIC CELLS EP04712328.6 2004-02-18 EP1641927A2 2006-04-05 Slawin, Kevin M.; Spencer, David; Hanks, Brent
The present invention is directed to a composition and method which treat diseases and enhance a regulated immune response. More particularly, the present invention is drawn to compositions that are based on dendritic cells modified to express an inducible form of a costimulatory polypeptide.
3 Induced activation in dendritic cells EP12179406.9 2004-02-18 EP2557164A1 2013-02-13 Slawin, Kevin M.; Spencer, David; Hanks, Brent

The present invention is directed to a composition and method which treat diseases and enhance a regulated immune response. More particularly, the present invention is drawn to compositions that are based on dendritic cells modified to express an inducible form of a costimulatory polypeptide.

4 Photocleavable linker US14083938 2013-11-19 US09096844B2 2015-08-04 John C. Williams; David Horne; Jun Xie; Shubbir Ahmed
There are provided, inter alia, photolabile compounds and methods useful for the formation of dimers of biological molecules and subsequent dissociation of the dimers.
5 Photocleavable linker US14754064 2015-06-29 US09260710B2 2016-02-16 John C. Williams; David Horne; Jun Xie; Shubbir Ahmed
There are provided, inter alia, photolabile compounds and methods useful for the formation of dimers of biological molecules and subsequent dissociation of the dimers.
6 PHOTOCLEAVABLE LINKER US14754064 2015-06-29 US20150291950A1 2015-10-15 John C. Williams; David Horne; Jun Xie; Shubbir Ahmed
There are provided, inter alia, photolabile compounds and methods useful for the formation of dimers of biological molecules and subsequent dissociation of the dimers.
7 INDUCED ACTIVATION IN DENDRITIC CELLS EP04712328.6 2004-02-18 EP1641927B1 2015-07-08 SLAWIN, Kevin; SPENCER, David; HANKS, Brent
The present invention is directed to a composition and method which treat diseases and enhance a regulated immune response. More particularly, the present invention is drawn to compositions that are based on dendritic cells modified to express an inducible form of a costimulatory polypeptide.
8 INDUCED ACTIVATION IN DENDRITIC CELLS EP04712328 2004-02-18 EP1641927A4 2006-11-02 SLAWIN KEVIN; SPENCER DAVID; HANKS BRENT
The present invention is directed to a composition and method which treat diseases and enhance a regulated immune response. More particularly, the present invention is drawn to compositions that are based on dendritic cells modified to express an inducible form of a costimulatory polypeptide.
9 INDUCED ACTIVATION IN DENDRITIC CELLS PCT/US2004004757 2004-02-18 WO2004073641A3 2005-03-24 SLAWIN KEVIN; SPENCER DAVID; HANKS BRENT
The present invention is directed to a composition and method which to treat diseases and to enhance a regulated immune response. More particularly, the present invention is drawn to compositions that are based on dendritic cells modified to express an inducible form of a co­stimulatory polypeptide.
QQ群二维码
意见反馈